Skip to content

Public FDA record

Z-2817-2015: CD4 (SK3), FITC; Contains CD4 FITC with gelatin and 0.1% sodium Azide. Catalog number 340133 in vitro di

Recall record Z-2817-2015 for Becton, Dickinson and Company, BD Biosciences. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2817-2015
Company in FDA record
Becton, Dickinson and Company, BD Biosciences
FDA classification date
Sep 24, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC.

Source facts

Action
Urgent Product Recall notification letters were sent to each customer on August 27, 2015 by certified mail.
Initiated
2015-08-27
Root cause
Under Investigation by firm
Terminated
2016-08-09
Distribution
Worldwide Distribution. US nationwide (TX, CA, NC, OH, SD, PA, CT, UT, MD, TX, GA), Argentina, Taiwan, Australia, Japan, China, New Zealand, Chile and Colombia.
Recall number
Z-2817-2015
Recall status
Terminated
CDRH record ID
139712
FDA classified
2015-09-24
Recall event number
72071

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗